Lifevantage (LFVN) Price to Sales (2010 - 2026)

Lifevantage (LFVN) has reported Price to Sales for 17 consecutive years, with 12.4 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 320.34% year-over-year to 12.4; the trailing twelve-month figure through Jun 2026 stood at 0.53 (down 25.05% YoY), and the FY2026 full-year result was 0.43, down 39.86% from the prior year.
• Price to Sales rose to 12.4 in Q2 2026 per LFVN's latest filing, from 1.25 in the prior quarter.
• Across five years, Price to Sales topped out at 12.4 in Q2 2026 and bottomed at 0.85 in Q1 2023.
• Historically, Price to Sales has averaged 2.37 across 5 years, with a median of 1.59 in 2024.
• The widest YoY moves for Price to Sales: up 320.34% in 2026, down 60.3% in 2026.
• Over 5 years, Price to Sales stood at 0.88 in 2022, then surged by 69.94% to 1.5 in 2023, then surged by 116.88% to 3.25 in 2024, then plunged by 50.42% to 1.61 in 2025, then surged by 670.22% to 12.4 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 12.4, 1.25, and 1.61 for Q2 2026, Q1 2026, and Q4 2025 respectively.